CIK 0001420565 · Non-accelerated filer<br>Smaller reporting company
Rein Therapeutics, Inc.
Sign in to watch- Ticker
- RNTX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 134196017
- Phone
- 7378021989
- Business address
- 12407 N. MOPAC EXPY., SUITE 250 #390, AUSTIN, TX, 78758
- Former names
- Aileron Therapeutics, Inc., AILERON THERAPEUTICS INC
- 424B5 Offering Prospectus
- EFFECT Other Notice of Effectiveness
- CORRESP Other Correspondence Between Filers and SEC Staff
- CORRESP Other Correspondence Between Filers and SEC Staff
- S-1 Offering Registration Statement
- 10-K/A Report 10-K/A
- 10-K Report Annual Report
- 8-K Event Material agreement · New debt or obligation · Unregistered share sale
- 8-K Event Executive or director change
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- 8-K Event Material agreement · New debt or obligation · Unregistered share sale
- UPLOAD Other SEC-generated Letter
- DRS Other Draft Registration Statement
- 8-K Event Agreement ended
- 4 Insider Changes in Ownership
- 10-Q Report Quarterly Report
- 8-K Event Other events
- 4 Insider Changes in Ownership
- 8-K Event Material agreement · New debt or obligation · Unregistered share sale
- 8-K Event Other events
Page 2 of 27 · 525 filings